NovaBay Pharmaceuticals, Inc.(NYSE Amex Equities : NBY)
(
)
Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Interested in Binary Options?
We'll teach you the best ways to trade binaries.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| CELG | Celgene Corporation | 0.01% | 90.69 | 1.3% | $836.99m | |
| AMGN | Amgen Inc. | 0.89% | 188.34 | 1.2% | $659.06m | |
| GILD | Gilead Sciences, Inc. | 1.84% | 67.59 | 0.9% | $528.28m | |
| BIIB | Biogen Inc. | 2.51% | 332.87 | 1.3% | $459.94m | |
| ILMN | Illumina, Inc. | 2.51% | 299.82 | 3.5% | $326.05m | |
| REGN | Regeneron Pharmaceuticals, Inc. | 2.17% | 423.97 | 2.6% | $322.32m | |
| VRTX | Vertex Pharmaceuticals Incorporated | 1.27% | 188.07 | 1.9% | $269.19m | |
| ALXN | Alexion Pharmaceuticals, Inc. | 2.77% | 129.42 | 2.0% | $243.58m | |
| A | Agilent Technologies, Inc. | 1.64% | 78.28 | 1.6% | $138.30m | |
| INCY | Incyte Corporation | 0.88% | 84.15 | 2.5% | $117.93m | |
| ALNY | Alnylam Pharmaceuticals, Inc | 0.60% | 83.53 | 9.2% | $73.46m | |
| SGEN | Seattle Genetics, Inc. | 4.24% | 71.48 | 6.6% | $70.53m | |
| BLUE | Bluebird Bio, Inc. | 2.04% | 137.03 | 14.4% | $66.91m | |
| NKTR | Nektar Therapeutics | -2.18% | 41.69 | 5.5% | $59.28m | |
| MGNX | MacroGenics, Inc. | 3.41% | 21.84 | 7.2% | $57.08m |
Company Profile
NovaBay Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in commercializing and developing products for eye care. Its products include Avenova, NeutroPhase, and CelleRx. The comapny was founded by Ramin Najafi on January 19, 2000 and is headquartered in Emeryville, CA.